This content is part of a paid partnership with Western Radiology. Recent data are reshaping how angina is approached. Firstly, a large RCT (the ISCHEMIA study) re-iterated that we need not automatically proceed to revascularisation for stable angina, given no clear mortality benefit in doing so (after excluding left main stem or high-grade 3 vessel disease, and of course unstable angina). Secondly, a sham-controlled RCT (ORBITA) showed that aggressively up-titrating anti-anginals often obviates any additional symptomatic gains from a stent, at least in the short term. Dr Adil Rajwani Historically, angina was frequently treated by percutaneous intervention. Now, after excluding…
This content is restricted to site members. If you are an existing user, please log in. New users may register below.